Westerterp Kr, Wilson SA, Rolland V
Lexi clarifies the misunderstood connection between GLP-1 agonists and thyroid health, and how this medication when supported by labs, nutrition, and exercise can reduce systemic inflammation and support metabolic healing
Additional information Prior Presentation Findings from this study have been previously presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Atlanta, Georgia, USA, from 5 to 8 May 2024, and at the American Diabetes Association (ADA)84th Annual Scientific Sessions in Orlando, Florida, USA, from 21 to 24 June 2024
Sequoia data finds that GLP-1 medications average around $1,000 per prescription, posing financial challenges for employers who provide health benefits
Take the First Step Towards a Healthier You Are you ready to explore the benefits of GLP-1 treatment
This expansion in use aligns with the growing recognition of obesity as a medical condition that demands effective treatment strategies